4 HEALTH INNOVATION NORGE AS: årsregnskap 2025 vs 2024
Weaker earnings, cash halved-plus
approved 2026-06-12; registry 2026-06-16; journal 2026 547627
Summary
What changed
Comparing Årsregnskap 2025 with 2024 for 4 HEALTH INNOVATION NORGE AS. Net result -442.9k NOK → -2.01m NOK. Equity 687.9k NOK → -1.32m NOK.
Pressures included: operating result weakened; net result weakened; equity eroded.
Also worth watching: thin equity buffer; book investments changed. All figures are taken from the published annual accounts for 4 HEALTH INNOVATION NORGE AS.
At a glance
Scorecard
What deteriorated
-
↓
Operating result weakened
Operating result -57.9k NOK → -176.3k NOK. Calculated
-
↓
Net result weakened
Net result -442.9k NOK → -2.01m NOK. Calculated
-
↓
Equity eroded
Book equity 687.9k NOK → -1.32m NOK (equity ratio 28.1% → -1850.2%). Calculated
-
↓
Cash fell
Bank deposits 1 255 NOK → 114 NOK (-90.9% YoY). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is -1850.2% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
Book investments changed
Investment / intangible book value 2.13m NOK → 2 126 NOK. Reported fact